Disclosure of Relationships
It is the policy of Baylor College of Medicine that the provider
and faculty disclose the existence of any significant financial
or other relationship with companies whose products or services
may be discussed in the activity, e.g., research grant support,
consultancies, etc.
The contributor listed below has disclosed a financial
interest or other relationship with a commercial concern related
directly or indirectly to this educational activity (names
of companies are listed after each contributor's name). Baylor
College of Medicine does not view the existence of these interests
or relationships as implying bias or decreasing the value
of the presentation.
The following contributor has reported no interest or other
relationships with companies whose products or services are
discussed in this activity: Marvin A. Fishman, MD.
Food and Drug Administration Disclosure
Some drugs and medical devices identified during this activity
have United States Food and Drug Administration (FDA) clearance
for the use of specific purposes only for use in restricted
research settings. The FDA has stated that it is the responsibility
of the physician to determine the FDA status of each drug
or device that he or she wishes to use in clinical practice
and to use these products in compliance with applicable law.
Baylor College of Medicine requires that all contributors
identify and disclose any "off-label" uses of pharmaceutical
and medical device products. Physicians are urged to fully
review all the available data on new products or procedures
before using them to treat patients.
The following contributor in this activity has reported no
discussion of "off-label" uses of pharmaceutical
or medical device products in his presentation: Marvin
A. Fishman, MD.
This online enduring material was produced by Baylor College
of Medicine, Office of Continuing Medical Education, with
the assistance of the Center for Collaborative and Interactive
Technologies, Baylor College of Medicine, Houston, Texas.
Page last modified on
July 31, 2008.
|